GKB Ophthalmics has informed that pursuant to Regulation 25 (3 and 4) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 and Schedule IV, clause VII of the Companies Acts, 2013, a separate meeting of the Independent Directors of GKB Ophthalmics, will be held on Thursday, March 27, 2025, at the Registered office of the Company, to transact the following business: 1. To review the performance of the Non- Independent Directors and the Board of Directors as a whole; 2. To review the performance of the Chairman of the Company taking into account the views of the Executive Director and Non - Executive Directors; 3. To assess the quality, quantity and timeliness of flow of information between the Company Management and the Board that is necessary for the Board to effectively and reasonably perform their duties; and 4. Any other matter with the permission of the Chair. Kindly take the information on record.
The above information is a part of company’s filings submitted to BSE.
